• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于可生物降解聚合物的载蛋白缓释纳米颗粒的制备、表征及体外评价

Preparation, characterization and in-vitro evaluation of sustained release protein-loaded nanoparticles based on biodegradable polymers.

作者信息

Mukherjee Biswajit, Santra Kousik, Pattnaik Gurudutta, Ghosh Soma

机构信息

Department of Pharmaceutical Technology, Jadavpur University, Kolkata, West Bengal, India.

出版信息

Int J Nanomedicine. 2008;3(4):487-96. doi: 10.2147/ijn.s3938.

DOI:10.2147/ijn.s3938
PMID:19337417
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2636584/
Abstract

Controlled drug delivery technology of proteins/peptides from biodegradable nanoparticles has emerged as one of the eminent areas to overcome formulation associated problems of the macromolecules. The purpose of the present investigation was to develop protein-loaded nanoparticles using biodegradable polymer poly L-lactide-co-glycolidic acid (PLGA) with bovine serum albumin (BSA) as a model protein. Despite many studies available with PLGA-based protein-loaded nanoparticles, production know-how, process parameters, protein loading, duration of protein release, narrowing polydispersity of particles have not been investigated enough to scale up manufacturing of protein-loaded nanoparticles in formulations. Different process parameters such as protein/polymer ratio, homogenizing speed during emulsifications, particle surface morphology and surface charges, particle size analysis and in-vitro protein release were investigated. The in-vitro protein release study suggests that release profile of BSA from nanoparticles could be modulated by changing protein-polymer ratios and/or by varying homogenizing speed during multiple-emulsion preparation technique. The formulation prepared with protein-polymer ratio of 1:60 at 17,500 rpm gave maximum protein-loading, minimum polydispersion with maximally sustained protein release pattern, among the prepared formulations. Decreased (10,000 rpm) or enhanced (24,000 rpm) homogenizing speeds resulted in increased polydispersion with larger particles having no better protein-loading and -release profiles in the present study.

摘要

基于可生物降解纳米颗粒的蛋白质/肽控释技术已成为克服大分子制剂相关问题的重要领域之一。本研究的目的是以牛血清白蛋白(BSA)作为模型蛋白,使用可生物降解聚合物聚丙交酯-乙交酯(PLGA)制备载蛋白纳米颗粒。尽管已有许多关于基于PLGA的载蛋白纳米颗粒的研究,但生产技术、工艺参数、蛋白载量、蛋白释放持续时间以及颗粒多分散性的缩小等方面尚未得到充分研究,不足以扩大制剂中载蛋白纳米颗粒的生产规模。研究了不同的工艺参数,如蛋白/聚合物比例、乳化过程中的均质速度、颗粒表面形态和表面电荷、粒径分析以及体外蛋白释放情况。体外蛋白释放研究表明,通过改变蛋白-聚合物比例和/或在复乳制备技术中改变均质速度,可以调节BSA从纳米颗粒中的释放曲线。在所制备的制剂中,以1:60的蛋白-聚合物比例在17,500转/分钟的条件下制备的制剂具有最大的蛋白载量、最小的多分散性以及最大程度的持续蛋白释放模式。在本研究中,降低(10,000转/分钟)或提高(24,000转/分钟)的均质速度会导致多分散性增加,颗粒变大,且蛋白载量和释放曲线并无改善。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbe3/2636584/d21617f7aad2/ijn-3-487f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbe3/2636584/9544471131b1/ijn-3-487f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbe3/2636584/588928eea815/ijn-3-487f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbe3/2636584/e0944a519209/ijn-3-487f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbe3/2636584/4e39867f03d8/ijn-3-487f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbe3/2636584/8ca70a735796/ijn-3-487f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbe3/2636584/910f39651558/ijn-3-487f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbe3/2636584/d21617f7aad2/ijn-3-487f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbe3/2636584/9544471131b1/ijn-3-487f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbe3/2636584/588928eea815/ijn-3-487f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbe3/2636584/e0944a519209/ijn-3-487f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbe3/2636584/4e39867f03d8/ijn-3-487f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbe3/2636584/8ca70a735796/ijn-3-487f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbe3/2636584/910f39651558/ijn-3-487f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbe3/2636584/d21617f7aad2/ijn-3-487f7.jpg

相似文献

1
Preparation, characterization and in-vitro evaluation of sustained release protein-loaded nanoparticles based on biodegradable polymers.基于可生物降解聚合物的载蛋白缓释纳米颗粒的制备、表征及体外评价
Int J Nanomedicine. 2008;3(4):487-96. doi: 10.2147/ijn.s3938.
2
High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: quality by design optimization and characterization.载药量高且能持续释放 siRNA 的 PLGA 纳米粒:基于质量源于设计的优化和表征。
Eur J Pharm Biopharm. 2011 Jan;77(1):26-35. doi: 10.1016/j.ejpb.2010.11.008. Epub 2010 Nov 18.
3
Nimodipine loaded PLGA nanoparticles: formulation optimization using factorial design, characterization and in vitro evaluation.载有尼莫地平的聚乳酸-羟基乙酸共聚物纳米颗粒:采用析因设计进行配方优化、表征及体外评价
Curr Drug Deliv. 2007 Jul;4(3):185-93. doi: 10.2174/156720107781023929.
4
A biodegradable polymeric system for peptide-protein delivery assembled with porous microspheres and nanoparticles, using an adsorption/infiltration process.采用吸附/渗透工艺,将多孔微球和纳米颗粒组装成用于肽-蛋白递药的可生物降解聚合物系统。
Int J Nanomedicine. 2013;8:2141-51. doi: 10.2147/IJN.S44482. Epub 2013 Jun 10.
5
Biodegradable nanoparticles for protein delivery: analysis of preparation conditions on particle morphology and protein loading, activity and sustained release properties.用于蛋白质递送的可生物降解纳米颗粒:制备条件对颗粒形态、蛋白质负载量、活性及缓释性能的分析
J Biomater Sci Polym Ed. 2012;23(9):1129-51. doi: 10.1163/092050611X576648. Epub 2012 May 8.
6
Development of biodegradable polymer based tamoxifen citrate loaded nanoparticles and effect of some manufacturing process parameters on them: a physicochemical and in-vitro evaluation.基于可生物降解聚合物的枸橼酸他莫昔芬载药纳米粒的研制及其部分制备工艺参数对其影响的理化性质和体外评价。
Int J Nanomedicine. 2010 Sep 7;5:621-30. doi: 10.2147/IJN.S9962.
7
Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins.壳聚糖和壳寡糖表面修饰聚合物纳米粒用于黏膜给蛋白递药:提高黏膜黏附性和细胞摄取。
Drug Deliv Transl Res. 2016 Aug;6(4):365-79. doi: 10.1007/s13346-016-0295-x.
8
Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.透明质酸锚定的阿霉素聚乳酸-羟基乙酸共聚物纳米颗粒载体的研制与表征
Nanomedicine. 2007 Dec;3(4):246-57. doi: 10.1016/j.nano.2007.09.004.
9
Loading and release of amphotericin-B from biodegradable poly(lactic-co-glycolic acid) nanoparticles.两性霉素 B 从可生物降解的聚(乳酸-共-乙醇酸)纳米粒中的载药和释放。
J Biomed Nanotechnol. 2011 Feb;7(1):118-20. doi: 10.1166/jbn.2011.1230.
10
PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats.聚乙二醇化聚乳酸-羟基乙酸共聚物纳米粒作为蛋白质载体:大鼠体内的合成、制备及生物分布
J Control Release. 2001 Apr 2;71(2):203-11. doi: 10.1016/s0168-3659(01)00218-8.

引用本文的文献

1
Preparing a Phytosome for Promoting Delivery Efficiency and Biological Activities of Methyl Jasmonate-Treated Adventitious Root Extract (DMARE).制备姜酮素植物药质体以提高茉莉酸甲酯处理的不定根提取物(DMARE)的递送效率和生物活性。
Biomolecules. 2024 Oct 10;14(10):1273. doi: 10.3390/biom14101273.
2
Synergistic effect of curcumin and tamoxifen loaded in pH-responsive gemini surfactant nanoparticles on breast cancer cells.载姜黄素和他莫昔芬的 pH 响应双子表面活性剂纳米粒对乳腺癌细胞的协同作用。
BMC Complement Med Ther. 2024 Sep 20;24(1):337. doi: 10.1186/s12906-024-04631-x.
3
Multifunctional injectable microspheres for osteoarthritis therapy via spatiotemporally modulating macrophage polarization and inflammation.

本文引用的文献

1
Long circulating PEGylated poly(D,L-lactide-co-glycolide) nanoparticulate delivery of Docetaxel to solid tumors.多西他赛的长循环聚乙二醇化聚(D,L-丙交酯-共-乙交酯)纳米颗粒向实体瘤的递送
J Drug Target. 2008 Jun;16(5):424-35. doi: 10.1080/10611860802088598.
2
Polymers for viral gene delivery.用于病毒基因递送的聚合物。
Expert Opin Drug Deliv. 2008 Apr;5(4):385-401. doi: 10.1517/17425247.5.4.385.
3
Preparation, characterization, and pharmacokinetic evaluation of puerarin submicron emulsion.葛根素亚微乳的制备、表征及药代动力学评价
通过时空调节巨噬细胞极化和炎症用于骨关节炎治疗的多功能可注射微球
NPJ Regen Med. 2024 Sep 17;9(1):22. doi: 10.1038/s41536-024-00368-w.
4
and Mycosynthesis of Metal Nanoparticles: Role of Their Secondary Metabolites.金属纳米颗粒的真菌合成:其次级代谢产物的作用
J Fungi (Basel). 2024 Jun 22;10(7):443. doi: 10.3390/jof10070443.
5
Nanoparticle-based inhibition of vascular endothelial growth factor receptors alleviates osteoarthritis pain and cartilage damage.基于纳米颗粒的血管内皮生长因子受体抑制减轻骨关节炎疼痛和软骨损伤。
Sci Adv. 2024 Feb 16;10(7):eadi5501. doi: 10.1126/sciadv.adi5501. Epub 2024 Feb 14.
6
A Machine Learning Approach for PLGA Nanoparticles in Antiviral Drug Delivery.一种用于聚乳酸-羟基乙酸共聚物纳米颗粒抗病毒药物递送的机器学习方法。
Pharmaceutics. 2023 Feb 2;15(2):495. doi: 10.3390/pharmaceutics15020495.
7
Targeting Fibronectin to Overcome Remyelination Failure in Multiple Sclerosis: The Need for Brain- and Lesion-Targeted Drug Delivery.靶向纤维连接蛋白克服多发性硬化症中的髓鞘再生失败:脑内和病灶靶向药物递送的必要性。
Int J Mol Sci. 2022 Jul 29;23(15):8418. doi: 10.3390/ijms23158418.
8
Hydroxyapatite Nanoparticles in Drug Delivery: Physicochemistry and Applications.药物递送中的羟基磷灰石纳米颗粒:物理化学与应用
Pharmaceutics. 2021 Oct 9;13(10):1642. doi: 10.3390/pharmaceutics13101642.
9
The impact of calcium phosphate on FITC-BSA loading of sonochemically prepared PLGA nanoparticles for inner ear drug delivery elucidated by two different fluorimetric quantification methods.通过两种不同的荧光定量方法阐明了磷酸钙对声化学制备的用于内耳药物输送的 PLGA 纳米粒中 FITC-BSA 负载的影响。
Ultrason Sonochem. 2021 Nov;79:105783. doi: 10.1016/j.ultsonch.2021.105783. Epub 2021 Oct 9.
10
Colon Targeted Protein Nanoparticles Loaded Suppositories : Effective against Intestinal Parasites.载有结肠靶向蛋白质纳米颗粒的栓剂:对肠道寄生虫有效。
Adv Pharm Bull. 2021 May;11(3):490-496. doi: 10.34172/apb.2021.056. Epub 2020 Jul 15.
PDA J Pharm Sci Technol. 2008 Jan-Feb;62(1):32-45.
4
Compatibility of the antitumoral beta-lapachone with different solid dosage forms excipients.抗肿瘤药物β-拉帕醌与不同固体剂型辅料的相容性。
J Pharm Biomed Anal. 2007 Nov 30;45(4):590-8. doi: 10.1016/j.jpba.2007.08.016. Epub 2007 Aug 19.
5
Preparation, characterization, cytotoxicity and transfection efficiency of poly(DL-lactide-co-glycolide) and poly(DL-lactic acid) cationic nanoparticles for controlled delivery of plasmid DNA.用于质粒DNA控释的聚(DL-丙交酯-共-乙交酯)和聚(DL-乳酸)阳离子纳米颗粒的制备、表征、细胞毒性及转染效率
Int J Pharm. 2007 Oct 1;343(1-2):247-54. doi: 10.1016/j.ijpharm.2007.05.023. Epub 2007 May 18.
6
Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo.用于口服给药的载有雌二醇的聚乳酸-羟基乙酸共聚物纳米颗粒:聚合物分子量和共聚物组成对体外和体内释放行为的影响
J Control Release. 2007 May 14;119(1):77-85. doi: 10.1016/j.jconrel.2007.01.016. Epub 2007 Feb 3.
7
Nanoparticles of poly(lactide)-tocopheryl polyethylene glycol succinate (PLA-TPGS) copolymers for protein drug delivery.用于蛋白质药物递送的聚(丙交酯)-生育酚聚乙二醇琥珀酸酯(PLA-TPGS)共聚物纳米颗粒。
Biomaterials. 2007 Apr;28(11):2041-50. doi: 10.1016/j.biomaterials.2007.01.003. Epub 2007 Jan 23.
8
Encapsulation of dexamethasone into biodegradable polymeric nanoparticles.将地塞米松包裹于可生物降解的聚合物纳米颗粒中。
Int J Pharm. 2007 Mar 1;331(2):153-9. doi: 10.1016/j.ijpharm.2006.11.028. Epub 2006 Nov 12.
9
Freeze-drying of nanoparticles: formulation, process and storage considerations.纳米颗粒的冷冻干燥:制剂、工艺及储存考量
Adv Drug Deliv Rev. 2006 Dec 30;58(15):1688-713. doi: 10.1016/j.addr.2006.09.017. Epub 2006 Oct 6.
10
Colloidal stability of pluronic F68-coated PLGA nanoparticles: a variety of stabilisation mechanisms.普朗尼克F68包被的聚乳酸-羟基乙酸共聚物纳米颗粒的胶体稳定性:多种稳定机制
J Colloid Interface Sci. 2006 Oct 15;302(2):522-9. doi: 10.1016/j.jcis.2006.07.031. Epub 2006 Jul 20.